Brief: Relay Therapeutics Q1 Net Income USD -81.387 Million
May 02 (Reuters) - Relay Therapeutics Q1 operating expenses USD 100.37 million. * Q1 operating income USD -90.363 million * Q1 basic EPS USD -0.62
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers